PRADAXA 40 MG GRANULADO RECUBIERTO

Boehringer Ingelheim International Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a458905102812ada
Drug Cima Aemps Name: PRADAXA 40 MG GRANULADO RECUBIERTO
Register Number: 108442027
Holder Company Name: Boehringer Ingelheim International Gmbh
Marketing Company Name: Boehringer Ingelheim Espana S.A.
Holder Company Detail Path: /organization/boehringer-ingelheim-international-gmbh
Authorization Date: 2022-03-08
Dosage Form: GRANULADO RECUBIERTO
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Boehringer Ingelheim International Gmbh
Company Detail Path: /organization/boehringer-ingelheim-international-gmbh

DABIGATRAN ETEXILATO MESILATO

46,12 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 8, 2022

Approval ID

a458905102812ada

Type

Standard